Guided Therapeutics (GTHP) Enterprise Value Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.12% |
| Sep 30, 2025 | 31.60% |
| Jun 30, 2025 | 24.68% |
| Mar 31, 2025 | -40.51% |
| Dec 31, 2024 | 15.47% |
| Mar 31, 2024 | -136.61% |
| Sep 30, 2023 | -59.87% |
| Jun 30, 2023 | -101.38% |
| Mar 31, 2023 | -89.09% |
| Dec 31, 2022 | -370.80% |
| Sep 30, 2022 | -105.27% |
| Jun 30, 2022 | -123.49% |
| Mar 31, 2022 | -273.31% |
| Dec 31, 2021 | -114.99% |
| Sep 30, 2021 | -166.83% |
| Jun 30, 2021 | -111.09% |
| Mar 31, 2021 | -86.01% |
| Dec 31, 2020 | -39.06% |
| Sep 30, 2020 | -27.56% |
| Jun 30, 2020 | 17.31% |
| Mar 31, 2020 | -3.13% |
| Dec 31, 2019 | -40.88% |
| Mar 31, 2019 | 34.56% |
| Sep 30, 2018 | 29.43% |
| Jun 30, 2018 | 53.95% |
| Mar 31, 2018 | 41.50% |
| Dec 31, 2017 | 75.10% |
| Sep 30, 2017 | 50.56% |
| Jun 30, 2017 | 64.07% |
| Mar 31, 2017 | 74.35% |
| Dec 31, 2016 | 63.28% |
| Sep 30, 2016 | 67.64% |
| Jun 30, 2016 | 60.69% |
| Mar 31, 2016 | 52.46% |
| Dec 31, 2015 | 59.38% |
| Jun 30, 2015 | -39.55% |